Skip to main content

Table 2 Program outcomes at the outpatient centers of Sabon Guida and Madaoua, Tahoua Region, Niger, June 2018–June 2019

From: A feasibility study using mid-upper arm circumference as the sole anthropometric criterion for admission and discharge in the outpatient treatment for severe acute malnutrition

 

Sabon Guida

MUAC-only program

(n = 1019)

Madaoua

Standard program

(n = 824)

      

n (%)

n (%)

Crude OR (95%CI)

p

Adjusteda OR (95%CI)

p

Adjustedb OR (95%CI)

p

All children

Type of discharge

1019

824

      

 Recovery

714 (70.1)

425 (51.6)

2.20 (1.81–2.66)

< 0.001

2.31 (1.79; 2.98)

< 0.001

1.68 (1.28; 2.22)

< 0.001

 Default

42 (4.1)

78 (9.5)

0.41 (0.28–0.61)

< 0.001

0.28 (0.17; 0.45)

< 0.001

0.36 (0.22;- 0.60)

< 0.001

 Death

21 (2.1)

15 (1.8)

1.13 (0.58–2.22)

0.711

1.44 (0.61; 3.44)

0.401

2.07 (0.84; 5.11)

0.112

 Non-response

231 (22.7)

294 (35.7)

0.53 (0.43–0.65)

< 0.001

0.57 (0.44; 0.75)

< 0.001

0.75 (0.56; 0.99)

0.047

 Transfer (to another outpatient center)

11 (1.1)

12 (1.5)

0.74 (0.32–1.68)

0.470

0.48 (0.16; 1.42)

0.189

0.53 (0.17; 1.65)

0.279

Children with MUAC < 115 mm upon admission

Type of discharge

492

543

      

 Recovery

272 (55.3)

234 (43.1)

1.63 (1.27; 2.08)

< 0.001

1.58 (1.14; 2.19)

0.005

1.60 (1.16; 2.23)

0.004

 Default

25 (5.1)

60 (11.1)

0.43 (0.26; 0.69)

< 0.001

0.29 (0.17; 0.54)

< 0.001

0.29 (0.16; 0.53)

< 0.001

 Death

14 (2.9)

10 (1.8)

1.56 (0.68; 3.54)

0.288

1.49 (0.54; 4.10)

0.434

1.48 (0.53; 4.06)

0.446

 Non-response

172 (35.0)

232 (42.7)

0.72 (0.56; 0.92)

0.011

0.90 (0.64; 1.25)

0.548

0.89 (0.64 1.25)

0.531

 Transfer (to another outpatient center)

9 (1.8)

7 (1.3)

1.42 (0.52; 3.86)

0.484

0.66 (1.94; 2.28)

0.519

0.66 (0.19; 2.29)

0.520

Children with MUAC ≥ 115 mm upon admission

Type of discharge

527

281

      

 Recovery

442 (83.9)

191 (67.9)

2.45 (1.74; 3.44)

< 0.001

2.57 (1.59; 4.15)

< 0.001

1.84 (1.05; 3.22)

0.032

 Default

17 (3.2)

18 (6.4)

0.48 (0.24; 0.96)

0.038

0.32 (0.13; 0.81)

0.015

0.60 (0.20; 1.88)

0.385

 Death

7 (1.3)

5 (1.7)

0.74 (0.23; 2.36)

0.615

2.64 (0.45; 15.59)

0.282

5.16 (0.45; 58.57)

0.185

 Non-response

59 (11.2)

62 (22.1)

0.44 (0.30; 0.65)

< 0.001

0.40 (0.23; 0.70)

0.001

0.51 (0.27; 0.95)

0.036

 Transfer (to another outpatient center)

2 (0.4)

5 (1.8)

0.21 (0.04–1.09)

0.063

0.24 (0.01; 3.36)

0.290

0.01 (0.00; 3.711)

0.133

Duration and response to treatment among recovered children

Crude mean difference (95%CI)

p

Adjusteda mean difference (95%CI)

p

Adjusteda mean difference (95%CI)

p

All children

714

425

      

Duration of treatment (days)

43.3

45.7

−2.5 (−4.2; − 0.7)

0.006

−2.9 (−5.3; − 0.6)

0.012

− 1.6 (− 4.0; 0.7)

0.181

Weight gain (g/kg/day)

3.6

4.8

−1.2 (− 1.5; − 1.0)

< 0.001

−1.2 (− 1.6; − 0.8)

< 0.001

− 0.8 (− 1.2; − 0.4)

< 0.001

MUAC gain (mm/day)

0.29

0.31

−0.02 (− 0.03; − 0.001)

0.038

− 0.01 (− 0.036; 0.01)

0.203

− 0.01 (− 0.03; 0.01)

0.506

Children with MUAC < 115 mm upon admission

272

234

      

Duration of treatment (days)

48.9

48.9

−0.002 (− 2.4; 2.4)

0.999

− 1.2 (− 4.3; 2.0)

0.468

−1.3 (− 4.5; 1.8)

0.416

Weight gain (g/kg/day)

4.1

4.8

− 0.7 (−1.1; − 0.3)

< 0.001

− 0.5 (− 1.0; − 0.03)

0.039

−0.6 (− 1.1; − 0.1)

0.015

MUAC gain (mm/day)

0.36

0.36

0.002 (−0.02; 0.02)

0.829

0.01 (−0.02; 0.04)

0.584

0.01 (−0.02; 0.04)

0.599

Children with MUAC ≥ 115 mm upon admission

442

191

      

Duration of treatment (days)

39.8

41.8

− 2.0 (− 4.4; 0.4)

0.096

−1.2 (− 4.5; 2.1)

0.463

−3.6 (−7.5; 0.30)

0.070

Weight gain (g/kg/day)

3.2

4.8

−1.6 (− 2.0; − 1.2)

< 0.001

−1.6 (− 2.2; − 1.1)

< 0.001

−1.1 (− 1.8; −0.5)

< 0.001

MUAC gain (mm/day)

0.25

0.25

−0.001 (− 0.02; 0.02)

0.900

0.00 (− 0.02; 0.035)

0.712

− 0.03 (− 0.06; 0.001)

0.057

  1. aAdjusted for age, sex, HAZ, and morbidities on admission
  2. bAdditionally adjusted for MUAC and WHZ on admission